BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9690701)

  • 1. Appetite suppressant drugs as inhibitors of human cytochromes P450: in vitro inhibition of P450-2D6 by D- and L-fenfluramine, but not phentermine.
    von Moltke LL; Greenblatt DJ; Ciraulo DA; Grassi JM; Granda BW; Duan SX; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 1998 Aug; 18(4):338-41. PubMed ID: 9690701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anesthetic considerations for the new antiobesity medications.
    Jeffers LA
    AANA J; 1996 Dec; 64(6):541-4. PubMed ID: 9204789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fenfluramine/phentermine combination for weight loss.
    Garrett SD; Cupp MJ
    Nurse Pract; 1997 Aug; 22(8):166, 168, 170. PubMed ID: 9279853
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
    Johnson GJ; Leis LA; Dunlop PC; Weir EK
    J Thromb Haemost; 2003 Dec; 1(12):2663-8. PubMed ID: 14675103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic interactions between fenfluramine and phentermine.
    Wellman PJ; Maher TJ
    Int J Obes Relat Metab Disord; 1999 Jul; 23(7):723-32. PubMed ID: 10454106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo.
    von Moltke LL; Greenblatt DJ; Duan SX; Daily JP; Harmatz JS; Shader RI
    J Pharm Sci; 1998 Oct; 87(10):1184-9. PubMed ID: 9758674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of drug-drug interaction for silymarin.
    Doehmer J; Tewes B; Klein KU; Gritzko K; Muschick H; Mengs U
    Toxicol In Vitro; 2008 Apr; 22(3):610-7. PubMed ID: 18249085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cimetidine on dextromethorphan O-demethylase activity of human liver microsomes and recombinant CYP2D6.
    Madeira M; Levine M; Chang TK; Mirfazaelian A; Bellward GD
    Drug Metab Dispos; 2004 Apr; 32(4):460-7. PubMed ID: 16680870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6.
    Desta Z; Wu GM; Morocho AM; Flockhart DA
    Drug Metab Dispos; 2002 Mar; 30(3):336-43. PubMed ID: 11854155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of fenfluramine, phenylpropanolamine, phentermine and diethylpropion on acoustic startle in rats.
    Kutscher CL
    Pharmacol Biochem Behav; 1987 Aug; 27(4):749-52. PubMed ID: 3659098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anorectic efficacy of the fenfluramine/phentermine combination in rats: additivity or synergy?
    Roth JD; Rowland NE
    Eur J Pharmacol; 1999 Jun; 373(2-3):127-34. PubMed ID: 10414430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir.
    von Moltke LL; Greenblatt DJ; Grassi JM; Granda BW; Duan SX; Fogelman SM; Daily JP; Harmatz JS; Shader RI
    J Clin Pharmacol; 1998 Feb; 38(2):106-11. PubMed ID: 9549640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phentermine and other monoamine-oxidase inhibitors may increase plasma serotonin when given with fenfluramines.
    Maher TJ; Ulus IH; Wurtman RJ
    Lancet; 1999 Jan; 353(9146):38. PubMed ID: 10023954
    [No Abstract]   [Full Text] [Related]  

  • 14. Supraadditive effect of d-fenfluramine plus phentermine on extracellular acetylcholine in the nucleus accumbens: possible mechanism for inhibition of excessive feeding and drug abuse.
    Rada PV; Hoebel BG
    Pharmacol Biochem Behav; 2000 Mar; 65(3):369-73. PubMed ID: 10683475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential for CYP2D6 inhibition screening using a novel scintillation proximity assay-based approach.
    Delaporte E; Slaughter DE; Egan MA; Gatto GJ; Santos A; Shelley J; Price E; Howells L; Dean DC; Rodrigues AD
    J Biomol Screen; 2001 Aug; 6(4):225-31. PubMed ID: 11689122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine.
    Wang RW; Liu L; Cheng H
    Drug Metab Dispos; 1996 Jul; 24(7):786-91. PubMed ID: 8818577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.
    AlRabiah H; Ahad A; Mostafa GAE; Al-Jenoobi FI
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):707-713. PubMed ID: 29744741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of phentermine and fenfluramine on alcohol consumption and alcohol withdrawal seizures in rats.
    Halladay AK; Fisher H; Wagner GC
    Alcohol; 2000 Jan; 20(1):19-29. PubMed ID: 10680713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the role of serotonin in the pathogenesis of pulmonary hypertension induced by anorectic drugs; an experimental study in the isolated perfused rat lung, II. Fenfluramine, mazindol, mefenorex, phentermine and R 800.
    Seiler KU; Wassermann O; Wensky H
    Clin Exp Pharmacol Physiol; 1976; 3(4):323-30. PubMed ID: 975621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fenfluramine and phentermine (fen-phen) on dopamine and serotonin release in rat striatum: in vivo microdialysis study in conscious animals.
    Balcioglu A; Wurtman RJ
    Brain Res; 1998 Nov; 813(1):67-72. PubMed ID: 9824670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.